These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9764823)

  • 1. Overexpression of fra-2 in transgenic mice perturbs normal eye development.
    McHenry JZ; Leon A; Matthaei KI; Cohen DR
    Oncogene; 1998 Sep; 17(9):1131-40. PubMed ID: 9764823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lens expression of TGF alpha in transgenic mice produces two distinct eye pathologies in the absence of tumors.
    Decsi A; Peiffer RL; Qiu T; Lee DC; Friday JT; Bautch VL
    Oncogene; 1994 Jul; 9(7):1965-75. PubMed ID: 8208543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
    Carrasco D; Bravo R
    Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice.
    Flügel-Koch C; Ohlmann A; Piatigorsky J; Tamm ER
    Dev Dyn; 2002 Oct; 225(2):111-25. PubMed ID: 12242711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
    Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
    Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterisation of the mouse fra-2 gene.
    Foletta VC; Sonobe MH; Suzuki T; Endo T; Iba H; Cohen DR
    Oncogene; 1994 Nov; 9(11):3305-11. PubMed ID: 7936655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.
    Smith M; Burke Z; Humphries A; Wells T; Klein D; Carter D; Baler R
    Mol Cell Biol; 2001 Jun; 21(11):3704-13. PubMed ID: 11340164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice.
    Flentjar N; Chu PY; Ng AY; Johnstone CN; Heath JK; Ernst M; Hertzog PJ; Pritchard MA
    Gastroenterology; 2007 Apr; 132(4):1410-9. PubMed ID: 17408644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of the nude gene induces hyperproliferation and defects in differentiation: implications for the self-renewal of cutaneous epithelia.
    Prowse DM; Lee D; Weiner L; Jiang N; Magro CM; Baden HP; Brissette JL
    Dev Biol; 1999 Aug; 212(1):54-67. PubMed ID: 10419685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
    Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
    Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and distribution of AP-1 transcription factors in the porcine ovary.
    Rusovici R; LaVoie HA
    Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
    Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
    Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials.
    Andersen H; Mahmood S; Tkach V; Cohn M; Kustikova O; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
    Oncogene; 2002 Jul; 21(31):4843-8. PubMed ID: 12101423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase-related protein 2 promoter targets transgene expression to ocular and neural crest-derived tissues.
    Zhao S; Overbeek PA
    Dev Biol; 1999 Dec; 216(1):154-63. PubMed ID: 10588869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
    Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
    Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.